跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
ACCEL-ONDANSETRON ODT - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
ACCEL-ONDANSETRON ODT
Authorized
STANDARD
ACCEL-ONDANSETRON ODT
accel pharma inc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
e69b594ea615a8f0
Company
accel pharma inc
Type
Standard
Approval Details
Approval Id
e69b594ea615a8f0
Drug Approval Canada Name
ACCEL-ONDANSETRON ODT
Product Name
ACCEL-ONDANSETRON ODT
Status
Marketed
Status Date
2023-12-19
Original Market Date
2023-12-19
Din
02535319
Drug Class
Human
Dosage Form
Tablet (Orally Disintegrating)
Route Of Administration
Oral
Schedule
Prescription
Ahfs
56:22.20
Atc Original
A04AA01 ONDANSETRON
Atc Name
a 04 aa 01
Aig Number
0131120003
Company Name
accel pharma inc
Company Address
119 Labrosse Ave, Pointe Claire, Quebec, Canada, H9R 1A3
Active Ingredients
ONDANSETRON
4 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
e69b594ea615a8f0
Type
Standard
Back to Health Canada Approvals